Condition: Respiratory Syncytial Virus Infections · Sponsor: Blue Lake Biotechnology Inc.
This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) and children (18-59 months of age) who may or may not have had prior respiratory syncytial virus (RSV) infection.
This description comes directly from the study's public registry record.
Henry Radziewicz, MD PhD · 585-313-0027 · HRadziewicz@bluelakebiotechnology.com
Nubia Kaba · 585-313-0027 · nkaba@cyanvacllc.com
Always discuss trial participation with your own doctor first.
| Paradigm Clinical Research | La Mesa, California, United States | Recruiting |
| Paradigm Clinical Research - Modesto | Modesto, California, United States | Recruiting |
| University of California, San Diego | San Diego, California, United States | Recruiting |
| Paradigm Clinical Research Centers, LLC - Colorado, 1550 South Potomac Street, Suite 340 | Aurora, Colorado, United States | Recruiting |
| Velocity Clinical Research, Boise | Meridian, Idaho, United States | Recruiting |
| Clinical Research Prime | Rexburg, Idaho, United States | Recruiting |
| AMR Newton | Newton, Kansas, United States | Recruiting |
| Velocity Clinical Research - Lafayette | Lafayette, Louisiana, United States | Recruiting |
| Michigan Institute of Research | Allen Park, Michigan, United States | Recruiting |
| Velocity Clinical Research, Grand Island | Grand Island, Nebraska, United States | Recruiting |
| Be Well Clinical Studies | Lincoln, Nebraska, United States | Recruiting |
| Velocity Clinical Research, Cleveland | Beachwood, Ohio, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05655182